Tegsedi
Ended Awarded Last action
- Contract number
- 36C25022N0640
- Awardee
-
Sobi, Inc. UEI S2TUAPDB2971
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $105,196
Award facts
- Contract value 100% obligated
- $105,195.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Bartlett, TN 38134, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award to Sobi, Inc., a foreign-owned, for-profit pharmaceutical company, provides for the delivery of TEGSEDI, a drug used to treat polyneuropathy of hereditary transthyretin-mediated amyloidosis. The $105,195.60 firm fixed price contract was issued by the U.S. Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 10, to support healthcare programs serving veterans.
The award is associated with two larger VA contract vehicles held by Sobi, Inc. - a multiple award schedule contract with a potential value of $78 million through July 2025, and a single award blanket purchase agreement valued at up to $11.75 million covering October 2021 to September 2024. These contracts, part of the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB), enable the VA to procure pharmaceuticals such as TEGSEDI and ORFADIN from Sobi, Inc. to aid in the treatment and care of veterans. The contract did not utilize any set-aside designations.
Quick answers
Who was awarded contract 36C25022N0640?
36C25022N0640 was awarded to Sobi, Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on June 15, 2022.
How much is contract 36C25022N0640 worth?
The government has obligated $105,196 on 36C25022N0640.
Is contract 36C25022N0640 an order under another contract?
Yes. 36C25022N0640 is a BPA call under 36F79720D0169-36E79721A0026, a blanket purchase agreement, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25022N0640 competed?
The extent of competition for 36C25022N0640 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award